Roc vs. Sux - The CURASMUR Trial

February 18, 2020 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

April 02, 2020 00:33:38
Episode Cover

Critical Care Management COVID-19 Update - March 30, 2020

Our understanding and management of patients with COVID-19 infection continues to rapidly evolve, almost on a daily basis.  In this podcast, we discuss current...

Listen

Episode 0

July 15, 2020 00:26:28
Episode Cover

TXA for GI Bleeds? The HALT-IT Trial

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in...

Listen

Episode 0

October 21, 2022 00:18:32
Episode Cover

Does the Timing of Source Control in Sepsis Make a Difference?

The emergency department resuscitation of patients with sepsis focuses on early recognition, timely administration of appropriate antibiotics, appropriate fluid resuscitation, early vasopressor initiation for...

Listen